Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389465 | SCV001590852 | pathogenic | Neurofibromatosis, type 1 | 2022-07-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr1296*) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of neurofibromatosis type 1 (PMID: 23913538). ClinVar contains an entry for this variant (Variation ID: 1075772). RNA analysis provides insufficient evidence to determine the effect of this variant on NF1 splicing (Invitae). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV002511085 | SCV002822382 | pathogenic | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | NF1: PVS1, PM2, PP4, PS4:Supporting |